Page last updated: 2024-11-05

triazolam and Sleep Initiation and Maintenance Disorders

triazolam has been researched along with Sleep Initiation and Maintenance Disorders in 170 studies

Triazolam: A short-acting benzodiazepine used in the treatment of insomnia. Some countries temporarily withdrew triazolam from the market because of concerns about adverse reactions, mostly psychological, associated with higher dose ranges. Its use at lower doses with appropriate care and labeling has been reaffirmed by the FDA and most other countries.

Sleep Initiation and Maintenance Disorders: Disorders characterized by impairment of the ability to initiate or maintain sleep. This may occur as a primary disorder or in association with another medical or psychiatric condition.

Research Excerpts

ExcerptRelevanceReference
"In a parallel-group, placebo-controlled, polysomnographic study with randomization, the possible occurrence of rebound insomnia was evaluated in 24 patients suffering from moderate to severe chronic insomnia and receiving either triazolam 0."9.07Zolpidem and rebound insomnia--a double-blind, controlled polysomnographic study in chronic insomniac patients. ( Attali, P; de la Giclais, B; Monti, D; Monti, JM; Morselli, PL; Zipfel, A, 1994)
"Within a double-blind, comparative study on the effects of the long-half-life benzodiazepine (BDZ), quazepam, and the short-half-life BDZ, triazolam, on clinical symptomatology, sleep and anxiety of 45 patients with insomnia based on a mild to moderate generalized anxiety disorder (GAD) (ICD-9 code: 307."9.07Insomnia in generalized anxiety disorder: polysomnographic, psychometric and clinical investigations before, during and after therapy with a long- versus a short-half-life benzodiazepine (quazepam versus triazolam). ( Anderer, P; Brandstätter, N; Frey, R; Grünberger, J; Klösch, G; Mandl, M; Saletu, B; Wetter, T; Zeitlhofer, J, 1994)
"A case of repetitive hallucinations during treatment with a therapeutic dosage of triazolam (0."7.69Hallucinations after a therapeutic dose of benzodiazepine hypnotics with co-administration of erythromycin. ( Kaneko, S; Kondo, T; Mihara, K; Morita, S; Otani, K; Tokinaga, N, 1996)
" The dosage was doubled after nights 2 and 9 if good sleep was not produced."6.64Multi-clinic cross-over comparison of triazolam (Halcion) and placebo in the treatment of co-existing insomnia and anxiety in anxious out-patients. ( Fabre, LF; Smith, WT, 1977)
"Triazolam is a triazolobenzodiazepine with hypnotic properties, advocated for use in acute or chronic insomnia, situational insomnia in hospitalised patients, and insomnia associated with other disease states."6.15Triazolam: a review of its pharmacological properties and therapeutic efficacy in patients with insomnia. ( Avery, GS; Brogden, RN; Heel, RC; Pakes, GE; Speight, TM, 1981)
"In a parallel-group, placebo-controlled, polysomnographic study with randomization, the possible occurrence of rebound insomnia was evaluated in 24 patients suffering from moderate to severe chronic insomnia and receiving either triazolam 0."5.07Zolpidem and rebound insomnia--a double-blind, controlled polysomnographic study in chronic insomniac patients. ( Attali, P; de la Giclais, B; Monti, D; Monti, JM; Morselli, PL; Zipfel, A, 1994)
"Within a double-blind, comparative study on the effects of the long-half-life benzodiazepine (BDZ), quazepam, and the short-half-life BDZ, triazolam, on clinical symptomatology, sleep and anxiety of 45 patients with insomnia based on a mild to moderate generalized anxiety disorder (GAD) (ICD-9 code: 307."5.07Insomnia in generalized anxiety disorder: polysomnographic, psychometric and clinical investigations before, during and after therapy with a long- versus a short-half-life benzodiazepine (quazepam versus triazolam). ( Anderer, P; Brandstätter, N; Frey, R; Grünberger, J; Klösch, G; Mandl, M; Saletu, B; Wetter, T; Zeitlhofer, J, 1994)
"A double-blind study comparing zopiclone and triazolam, in 48 healthy, chronic insomniacs, was undertaken in two centers to compare the hypnotic and withdrawal effects of both compounds."5.06A comparison of the efficacy, safety and withdrawal effects of zopiclone and triazolam in the treatment of insomnia. ( Bourgouin, J; Fleming, JA; Mayes, C; McClure, DJ; Phillips, R, 1990)
"Twelve volunteers with a complaint of chronic insomnia participated in a placebo-controlled, double-blind, crossover study of the effects of buspirone t."5.05Buspirone: an anxiolytic without sedative effect. ( Bliwise, NG; Cohen, SA; Dement, WC; Seidel, WF, 1985)
"6 mg) or flurazepam (30 mg) was given to chronic insomniac patients for 7 consecutive nights in parallel, double-blind design."5.04Methodology for demonstrating sustained efficacy of hypnotics: a comparative study of triazolam and flurazepam. ( Lasagna, L; Sundaresan, PR; Wardell, WM; Weintraub, M, 1979)
"A case of repetitive hallucinations during treatment with a therapeutic dosage of triazolam (0."3.69Hallucinations after a therapeutic dose of benzodiazepine hypnotics with co-administration of erythromycin. ( Kaneko, S; Kondo, T; Mihara, K; Morita, S; Otani, K; Tokinaga, N, 1996)
"Insomnia and anxiety decreased in 12 outpatients taking triazolam following alcohol withdrawal."3.65Pilot open-label study of triazolam in the treatment of insomnia following alcohol withdrawal. ( Fabre, LF; Gainey, A; Kemple, S; McLendon, DM; Metzler, CM, 1977)
"It has been reported that insomnia characterized by difficulty returning to sleep following a nocturnal awakening, otherwise defined as the middle-of-the-night (MOTN) insomnia, is a common form of insomnia in adults with growing prevalence by increasing age."2.84Effects of different doses of triazolam in the middle-of-the-night insomnia: a double-blind, randomized, parallel group study. ( Biggio, G; Ferini Strambi, L; Galbiati, A; Marelli, S; Zucconi, M, 2017)
"Previous studies have shown that insomniacs self-administer hypnotics at high nightly rates."2.70Treatment regimen and hypnotic self-administration. ( Bonahoom, A; Pedrosi, B; Roehrs, T; Rosenthal, L; Roth, T, 2001)
"Rebound effects after withdrawal from hypnotics are believed to trigger their chronic use and to enhance the risk of tolerance and dependence."2.70A double-blind, randomized and placebo-controlled study on the polysomnographic withdrawal effects of zopiclone, zolpidem and triazolam in healthy subjects. ( Backhaus, J; Berger, M; Feige, B; Hohagen, F; Hornyak, M; Riemann, D; Voderholzer, U, 2001)
"More triazolam was chosen at night than during the day."2.70Nighttime versus daytime hypnotic self-administration. ( Bonahoom, A; Pedrosi, B; Roehrs, T; Roth, T; Zorick, F, 2002)
"However, on the fourth day night-time insomnia induced by BL had recovered, and naps were shorter than the baseline."2.69Bright light treatment for night-time insomnia and daytime sleepiness in elderly people: comparison with a short-acting hypnotic. ( Fukuzawa, H; Ishizuka, Y; Kanba, S; Matsushita, Y; Usui, A, 2000)
"Triazolam was self administered as many nights as placebo, but the number of placebo capsules self administered was twice that of triazolam capsules."2.68Hypnotic self administration and dose escalation. ( Pedrosi, B; Roehrs, T; Rosenthal, L; Roth, T, 1996)
"Since homogeneous samples of insomniacs are difficult to recruit for pharmacotherapy studies, normal sleepers can be used to assess the protective effect of hypnotic drugs, under standardized nonconducive conditions."2.68Multidrug comparison (lorazepam, triazolam, zolpidem, and zopiclone) in situational insomnia: polysomnographic analysis by means of the cyclic alternating pattern. ( Boselli, M; Parrino, L; Smerieri, A; Spaggiari, MC; Terzano, MG, 1997)
"The zolpidem group was bracketed by a placebo group and a positive control group taking 0."2.68Minimal rebound insomnia after treatment with 10-mg zolpidem. ( Roehrs, T; Roth, T; Scharf, MB; Vogel, GW; Walsh, JK; Ware, JC, 1997)
"Twenty-four men and women with insomnia, age 21-50 years, self administered hypnotics under a single-choice with placebo, single-choice with triazolam (0."2.68Hypnotic self administration: forced-choice versus single-choice. ( Pedrosi, B; Roehrs, T; Rosenthal, L; Roth, T; Zorick, F, 1997)
"This study asks whether insomniacs undergoing behavioral training need to do so while totally free of hypnotics."2.68Can we mix behavioral therapy with hypnotics when treating insomniacs? ( Hauri, PJ, 1997)
"With temazepam this effect was more variable, with total wake time increased only with the second withdrawal period (39%)."2.67Rebound insomnia after only brief and intermittent use of rapidly eliminated benzodiazepines. ( Bixler, EO; Fee, EC; Kales, A; Manfredi, RL; Vela-Bueno, A; Vgontzas, AN, 1991)
" In this double-blind study in geriatric patients, drugs were administered during 3 weeks and the therapeutic effects of zopiclone at optimal dosage (5 or 7."2.67Efficacy and safety of zopiclone and triazolam in the treatment of geriatric insomniacs. ( Bourgouin, J; Elie, R; Frenay, M; Le Morvan, P, 1990)
"Triazolam-treated patients presented significantly more day-time-interdose anxiety than zopiclone as assessed by the weekly HARS and Clinical Global Assessment of Anxiety."2.67Zopiclone and triazolam in insomnia associated with generalized anxiety disorder: a placebo-controlled evaluation of efficacy and daytime anxiety. ( Beauclair, L; Beaudry, P; Chouinard, G; Fontaine, R; Le Morvan, P, 1990)
"Triazolam treatment showed superior immediate treatment effects, while behavioral treatment showed superior treatment effects at follow-up, effects that accrued during the training period and differentially persisted at follow-up."2.67Efficacy of behavioral versus triazolam treatment in persistent sleep-onset insomnia. ( McClusky, HY; Milby, JB; Switzer, PK; Williams, V; Wooten, V, 1991)
"Rebound insomnia, a worsening of sleep difficulty beyond baseline levels, can complicate the physician's attempt to use regularly scheduled drug holidays in the management of insomniac patients."2.67Feasibility of an every-other-night regimen in insomniac patients: subjective hypnotic effectiveness of quazepam, triazolam, and placebo. ( Scharf, MB, 1993)
"178 patients suffering from insomnia were included in the study, data from 139 patients were used in the analyses."2.67Randomized, double blind trial of zolpidem 10 mg versus triazolam 0.25 mg for treatment of insomnia in general practice. ( Ahlstrøm, F; Rosenberg, J, 1994)
"Rebound insomnia was studied in subjects, aged 25-50 years, with insomnia complaints and normal sleep, insomnia complaints and disturbed sleep, and normal sleep with no complaints (N = 21, n = 7 per group)."2.67Rebound insomnia in normals and patients with insomnia after abrupt and tapered discontinuation. ( Merlotti, L; Roehrs, T; Roth, T; Zorick, F, 1992)
"The groups compared were patients with insomnia and disturbed sleep, insomnia and normal sleep, and healthy normals."2.67Rebound insomnia and hypnotic self administration. ( Merlotti, L; Roehrs, T; Roth, T; Zorick, F, 1992)
"Subjects with rebound insomnia had poorer baseline sleep and a greater drug effect than did subjects without."2.67Rebound insomnia: duration of use and individual differences. ( Merlotti, L; Roehrs, T; Roth, T; Zorick, F, 1991)
"The study subjects were chronic insomniacs with moderate levels of psychopathology and prior use of hypnotics."2.66Profile of mood states changes during and after 5 weeks of nightly triazolam administration. ( Bliwise, DL; Bliwise, NG; Cohen, SA; Dement, WC; Seidel, WF, 1988)
"In patients without severe waking hypoxemia and without carbon dioxide retention, triazolam did not increase either nocturnal hypoxemia or respiratory events during sleep."2.66Effect of triazolam on sleep and arterial oxygen saturation in patients with chronic obstructive pulmonary disease. ( Dawson, A; Hajdukovic, RM; Mitler, MM; Timms, RM, 1988)
"Sixty volunteers with insomnia participated in a randomized, double-blind, controlled clinical trial."2.66Effect of gradual withdrawal on the rebound sleep disorder after discontinuation of triazolam. ( Greenblatt, DJ; Harmatz, JS; Shader, RI; Zinny, MA, 1987)
"Triazolam was administered to five psychiatric inpatients for a two-week period."2.66Behavioral side effects of triazolam in psychiatric inpatients: report of five cases. ( Bergiannaki, JD; Sakkas, PN; Soldatos, CR; Stefanis, CN, 1986)
"Chlormethiazole and triazolam were found to be similarly effective in short-term use."2.66A double-blind controlled study of chlormethiazole and triazolam as hypnotics in the elderly. ( Bayer, AJ; Bayer, EM; Pathy, MS; Stoker, MJ, 1986)
" In contrast, triazolam dosing did not significantly improve any of the major sleep efficiency parameters, and there was a rapid development of tolerance for the drug's slight initial effectiveness."2.66Comparison of short and long half-life benzodiazepine hypnotics: triazolam and quazepam. ( Bixler, EO; Kales, A; Manfredi, RL; Niklaus, DE; Soldatos, CR; Vela-Bueno, A, 1986)
"Triazolam, 0."2.66Dose-related effects of triazolam and flurazepam on a circadian rhythm insomnia. ( Bliwise, NG; Cohen, SA; Dement, WC; Roth, T; Seidel, WF, 1986)
" The recovery data compared favourably with those improvements noted during chronic administration of triazolam."2.65Chronic use of triazolam: the effects on the sleep patterns of insomniacs. ( Hyde, P; Linton, P; Pegram, V, 1980)
"Triazolam 0."2.65The efficacy of triazolam and chloral hydrate in geriatric insomniacs. ( Grissom, T; Kramer, M; Lutz, T; Piccione, P; Roth, T; Zorick, F, 1980)
"Sixty young male patients with insomniac disorders were treated with nitrazepam 5 mg or triazolam 0."2.65Comparison of nitrazepam 5 mg with triazolam 0.5 mg in young psychiatric insomniac inpatients. Double-blind single night cross-over study. ( Blumenthal, M; Byring, R; Koivula, K, 1980)
" It is concluded that both active drugs were highly effective, with a minimum of side effects, in this type of insomnia and with the relatively low dosage used."2.65Triazolam (Halcion) versus flunitrazepam (Rohypnol) against midwinter insomnia in Northern Norway. ( Bratlid, T; Lingjaerde, O, 1981)
"Triazolam (0."2.64Comparative efficacy of triazolam, flurazepam and placebo in out-patients insomniacs. ( Bowen, AJ, 1978)
"Triazolam 0."2.64A clinical comparison of triazolam with placebo and with secobarbital in insomniac patients. ( Allens, GS; Okawa, KK, 1978)
"Triazolam did not produce evidence of tolerance development after 2 weeks of treatment."2.64Multi-clinic double-blind comparison of triazolam (Halcion) and placebo administered for 14 consecutive nights in outpatients with insomnia. ( Brachfeld, J; Calvo, R; Fabre, LF; Metzler, C; Meyer, LR; Slowe, IA, 1978)
"Experimental sleep disturbance (model insomnia) was produced by intermittent white noise and the administration of 10 mg of methylphenidate (MPD)."2.64Model insomnia, noise, and methylphenidate, used for the evaluation of hypnotic drugs. ( Honda, H; Okuma, T, 1978)
" The dosage was doubled after nights 2 and 9 if good sleep was not produced."2.64Multi-clinic cross-over comparison of triazolam (Halcion) and placebo in the treatment of co-existing insomnia and anxiety in anxious out-patients. ( Fabre, LF; Smith, WT, 1977)
"Triazolam was more successful than methyprylon in this respect (p=0-012)."2.64Hypnotic efficacy of triazolam and methyprylon ininsomniac in-patients. ( Linet, OI; Lomen, P, 1976)
"Triazolam 0-5 mg was found to be preferred and to be superior to placebo, flurazepam and chloral hydrate in the treatment of insomnia."2.64Preference studies of triazolam with standard hypnotics in out-patients with insomnia. ( Fabre, LF; Harris, RT; McLendon, DM, 1976)
"Rebound insomnia, reported intermittently with most of these agents, was short-lived and not clinically significant."2.38Comparative clinical profiles of triazolam versus other shorter-acting hypnotics. ( Coleman, BS; Jonas, JM; Kalinske, RW; Sheridan, AQ, 1992)
"Rebound insomnia, a worsening of sleep compared with pretreatment levels, has been reported upon discontinuation of short half-life benzodiazepine hypnotics."2.38Rebound insomnia: a critical review. ( Gillin, JC; Johnson, LC; Spinweber, CL, 1989)
"In general, chronic insomniacs showed all degrees of daytime alertness regardless of nocturnal sleep parameters."2.37Issues in the diagnosis and treatment of insomnia. ( Carskadon, M; Dement, W; Seidel, W, 1984)
"In the small number of patients with chronic insomnia who have received extended treatment with loprazolam, no evidence of tolerance has occurred, although rebound insomnia was evident 3 days after drug withdrawal in several studies."2.37Loprazolam. A preliminary review of its pharmacodynamic and pharmacokinetic properties and therapeutic efficacy in insomnia. ( Clark, BG; Dawson, GW; Jue, SG; Ward, A, 1986)
"Flurazepam is a long elimination half-life drug, and there is significant daytime sedation during short term use; with continued use this effect diminishes."2.36Sleep laboratory studies of hypnotic drugs: efficacy and withdrawal effects. ( Kales, A; Kales, JD, 1983)
"The diagnosis and treatment of insomnia is a major clinical issue."2.36Rational basis for the use of sleeping pills. ( Dement, WC, 1983)
" Although some studies showed the possibility of adverse effects of triazolam in older people, there have been few studies investigating these effects in a clinical setting."1.43Quantification of adverse effects of regular use of triazolam on clinical outcomes for older people with insomnia: a retrospective cohort study. ( Babazono, A; Maeda, T; Nishi, T; Yasui, M, 2016)
"This paper addresses the pharmacokinetic properties of eszopiclone and the extent to which the longer half-life of eszopiclone compared to other commonly used hypnotics (immediate-release zolpidem, modified-release zolpidem, triazolam, zaleplon) may translate into either improved efficacy in enhancing sleep maintenance, or increased probability of residual sedative or performance-impairing effects."1.38Pharmacokinetic evaluation of eszopiclone: clinical and therapeutic implications. ( Greenblatt, DJ; Zammit, GK, 2012)
"Triazolam was associated with longer total sleep time and increased Stage 2 sleep."1.36Retrograde effects of triazolam and zolpidem on sleep-dependent motor learning in humans. ( Kehne, JH; Malison, RT; Morgan, PT; Sprenger, KJ, 2010)
"Rates of insomnia visits are somewhat higher for middle-aged (45 to 64 years of age) women, and data for female insomniacs suggest a trend toward diagnoses of depression compared with other (somatic) diagnoses for men."1.29Management of insomnia in office-based practice. National prevalence and therapeutic patterns. ( Brunton, SA; Radecki, SE, 1993)
", type of insomnia, type of physician who prescribed the drug) variables; (2) to estimate the proportion of long-term users (> 3 mo); (3) to determine the frequency of different administration schedules; (4) to determine whether the kind of hypnotic drug prescribed according to the duration of its effect correlates with the type of sleep disorder or patient age; and (5) to compare the dosage used by the elderly with that used by adults."1.29Hypnotic drug use in Spain: a cross-sectional study based on a network of community pharmacies. Spanish Group for the Study of Hypnotic Drug Utilization. ( Alvarez, C; DeAbajo, FJ; del Barrio, H; Madurga, M; Montero, D; Palop, R; Rayón, P; Serrano-Castro, M, 1996)
"Findings from a four-city study of the beneficial and adverse effects of hypnotics are reported."1.28The beneficial and adverse effects of hypnotics. ( Balter, MB; Uhlenhuth, EH, 1991)
"Two noncontinuous sleep disturbances, insomnia in the elderly and transient insomnia in young and middle-aged adults, are probably the most acceptable indications for the use of benzodiazepines."1.28Clinical uses and advantages of low doses of benzodiazepine hypnotics. ( Vogel, G, 1992)
"We conclude that the evaluation of insomnia by nonpsychiatrists is often incomplete and that hypnotic drugs may be inappropriately prescribed by these physicians."1.28Diagnosis and treatment of outpatient insomnia by psychiatric and nonpsychiatric physicians. ( Bauwens, SF; Shorr, RI, 1992)
"Triazolam 0."1.27Triazolam as a hypnotic for geriatric patients. A double-blind cross-over comparison of nitrazepam and triazolam regarding effects on sleep and psychomotor performance. ( Björnson, G; Dehlin, O, 1983)
"Early morning insomnia, a significant increase in wakefulness during the final hours of drug nights, occurred after 1 or 2 weeks of nightly administration of benzodiazepine hypnotics with short elimination half-lives, when tolerance had begun to develop."1.27Early morning insomnia with rapidly eliminated benzodiazepines. ( Bixler, EO; Kales, A; Kales, JD; Soldatos, CR, 1983)
"Side effects involving agitation, e."1.27Agitation observed during treatment with newer hypnotic drugs. ( Regestein, QR; Reich, P, 1985)
" This study used nocturnal polysomnography and daytime sleep/wake tendency measures (Multiple Sleep Latency Test, MSLT) to assess the efficacy and safety of a reduced triazolam dosage (0."1.27Efficacy of a reduced triazolam dose in elderly insomniacs. ( Roehrs, T; Roth, T; Wittig, R; Zorick, F, 1985)
"Rebound insomnia, a worsening of sleep compared with baseline, occurred following withdrawal of triazolam, nitrazepam, and flunitrazepam after they had been given in only single, nightly doses for short periods."1.26Rebound insomnia. A potential hazard following withdrawal of certain benzodiazepines. ( Kales, A; Kales, JD; Scharf, MB; Soldatos, CR, 1979)
"Rebound insomnia followed the withdrawal of three benzodiazepine hypnotic drugs, each of which had been administered in a single nightly dose for only short-term periods."1.26Rebound insomnia: a new clinical syndrome. ( Kales, A; Kales, JD; Scharf, MB, 1978)
"Triazolam proved to be an effective hypnotic during the six weeks of treatment, with no withdrawal effects upon discontinuation."1.26[Effects of the chronic administration of triazolam 0.50 mg on the sleep of insomniacs]. ( Kaffeman, M; Roth, T; Sicklesteel, J; Stepanski, E; Zorick, F, 1982)

Research

Studies (170)

TimeframeStudies, this research(%)All Research%
pre-199094 (55.29)18.7374
1990's61 (35.88)18.2507
2000's10 (5.88)29.6817
2010's5 (2.94)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Ferini Strambi, L1
Marelli, S1
Zucconi, M2
Galbiati, A1
Biggio, G1
Min, JY1
Min, KB1
Maeda, T1
Babazono, A1
Nishi, T1
Yasui, M1
Hirase, M1
Ishida, T1
Kamei, C1
Wisor, JP1
Jiang, P1
Striz, M1
O'Hara, BF1
Morgan, PT1
Kehne, JH1
Sprenger, KJ1
Malison, RT1
Greenblatt, DJ3
Zammit, GK1
Noguchi, H1
Kitazumi, K1
Mori, M1
Shiba, T1
Kumar, A1
Kulkarni, SK1
Cotroneo, A1
Gareri, P1
Nicoletti, N1
Lacava, R1
Grassone, D1
Maina, E1
De Sarro, G1
Cabodi, S1
Poitras, R1
Pegram, V1
Hyde, P1
Linton, P1
Bentel, H1
Piccione, P1
Zorick, F9
Lutz, T2
Grissom, T1
Kramer, M2
Roth, T15
Venuti, A1
Saitta, FP1
Gioffrè Micali, M1
Giorgianni, G1
Micali, B1
Blumenthal, M1
Byring, R1
Koivula, K1
Pakes, GE1
Brogden, RN1
Heel, RC1
Speight, TM1
Avery, GS1
Sbarbaro, V1
Gambina, G1
Bovi, P1
Trabucco, G1
Signori, L1
Varricchio, MC1
Lingjaerde, O1
Bratlid, T1
Kudo, Y1
Cirignotta, F1
De Anna, M1
Mondini, S1
Baruzzi, A1
Dement, W3
Seidel, W3
Carskadon, M2
Muzet, A2
Johnson, LC3
Spinweber, CL3
Stepanski, E1
Kaffeman, M1
Sicklesteel, J1
Murphy, P1
Hindmarch, I2
Hyland, CM1
Carskadon, MA1
Seidel, WF5
Dement, WC6
Kales, A11
Soldatos, CR6
Bixler, EO7
Kales, JD6
Rickels, K1
Purpura, RP1
Dordain, G1
Puech, AJ1
Simon, P1
Macleod, N1
Ellingsen, PA1
Dehlin, O1
Björnson, G1
Fleming, JA3
Bliwise, D1
Karacan, I1
Mitler, M1
Boyd, DH1
Ankier, SI2
Costa E Silva, JA1
Acioli, A1
Naylor, C1
Jones Da Silva, C1
Ferreira, I1
Dahl, LE1
Dencker, SJ1
Lundin, L1
Kullingsjö, H1
Cohn, JB2
Di Perri, R1
Feldbaum, JS1
Libert, JP1
Weber, LD1
Amoros, C1
Ehrhart, J1
Follenius, M1
Oswald, I1
Nicholson, AN2
Ladewig, D1
Labrecque, G1
Hajak, G2
Clarenbach, P2
Fischer, W2
Haase, W1
Rüther, E2
Ando, K1
Hayakawa, T1
Ohta, T2
Kayukawa, Y1
Ito, A1
Iwata, T2
Okada, T2
Monti, JM1
Attali, P1
Monti, D1
Zipfel, A1
de la Giclais, B1
Morselli, PL1
Rosenberg, J1
Ahlstrøm, F1
Miyagawa, M1
Hayasaka, S1
Noda, S1
Landy, DA1
Fairweather, DB1
Rombaut, N1
O'Donovan, MC1
McGuffin, P1
Radecki, SE1
Brunton, SA1
Saletu, B1
Anderer, P1
Brandstätter, N1
Frey, R1
Grünberger, J1
Klösch, G1
Mandl, M1
Wetter, T1
Zeitlhofer, J1
Milby, JB2
Williams, V2
Hall, JN1
Khuder, S1
McGill, T1
Wooten, V2
Scharf, MB5
Terzano, MG2
Parrino, L2
Boselli, M2
Dell'Orso, S1
Moroni, M1
Spaggiari, MC2
Bourin, M1
Malinge, M1
Roehrs, T9
Pedrosi, B4
Rosenthal, L3
Rayón, P1
Serrano-Castro, M1
del Barrio, H1
Alvarez, C1
Montero, D1
Madurga, M1
Palop, R1
DeAbajo, FJ1
Tokinaga, N1
Kondo, T1
Kaneko, S1
Otani, K1
Mihara, K1
Morita, S1
Guthrie, SK1
Sung, JC1
Goodson, J1
Grunhaus, L1
Tandon, R1
Ware, JC1
Walsh, JK2
Vogel, GW1
Lobo, BL2
Greene, WL2
Muzychenko, AP1
Prokudin, VN1
Bogdan, AN1
Smerieri, A1
Holt, RJ1
Allard, S1
Hauri, PJ1
Rodenbeck, A1
Bandelow, B1
Broocks, A1
Bunney, WE1
Azarnoff, DL1
Brown, BW1
Cancro, R1
Gibbons, RD1
Gillin, JC2
Hullett, S1
Killam, KF1
Kupfer, DJ1
Krystal, JH1
Stolley, PD1
French, GS1
Pope, AM1
Klein, DF1
Dunner, DL1
Smirne, S1
Ferini-Strambi, L1
Usui, A1
Ishizuka, Y1
Matsushita, Y1
Fukuzawa, H1
Kanba, S2
Bonahoom, A2
Voderholzer, U1
Riemann, D1
Hornyak, M1
Backhaus, J1
Feige, B1
Berger, M1
Hohagen, F1
Kanda, T1
Yokosuka, O1
Fujiwara, K1
Saisho, H1
Shiga, H1
Oda, S1
Okuda, K1
Sugawara, Y1
Makuuchi, M1
Hirasawa, H1
Fabre, LF5
Smith, WT1
Lomen, P1
Linet, OI1
McLendon, DM2
Harris, RT1
Gross, L1
Pasigajen, V1
Metzler, C2
Gainey, A1
Kemple, S1
Metzler, CM1
Brachfeld, J1
Meyer, LR1
Slowe, IA1
Calvo, R1
Okawa, KK1
Allens, GS1
Bowen, AJ1
Sundaresan, PR1
Wardell, WM1
Weintraub, M1
Lasagna, L1
Nair, NP1
Schwartz, G1
Okuma, T1
Honda, H1
Jonas, JM1
Coleman, BS1
Sheridan, AQ1
Kalinske, RW1
Nakra, BR1
Gfeller, JD1
Hassan, R1
Merlotti, L3
Klett, CJ1
Rothschild, AJ1
Vogel, G1
Shorr, RI1
Bauwens, SF1
Menkes, DB1
Miyaoka, H1
Terada, H1
Shima, S1
Yagi, G1
Asai, M1
Nishikawa, T1
Manfredi, RL3
Vgontzas, AN2
Tyson, KL1
Mahowald, MW1
Lauerma, H1
Roehrs, TA1
Weingartner, HJ1
Eckardt, MJ1
Hommer, DW1
Mendelson, W1
Wolkowitz, OM1
Perry, PJ1
Smith, DA1
McClusky, HY1
Switzer, PK1
Weatherall, M1
Vela-Bueno, A3
Fee, EC1
Balter, MB1
Uhlenhuth, EH1
Chaudoir, PJ1
Bodkin, NL1
O'Donnell, J1
Anderson, A1
Holland, RL1
McClure, DJ1
Mayes, C1
Phillips, R1
Bourgouin, J2
Elie, R1
Frenay, M1
Le Morvan, P2
Mouret, J1
Ruel, D1
Maillard, F2
Bianchi, M1
Fontaine, R1
Beaudry, P1
Beauclair, L1
Chouinard, G1
Mamelak, M2
Csima, A2
Price, V2
Rapport, DJ1
Covington, EC1
De Tullio, P1
Kirking, DM1
Zacardelli, DK1
Kwee, P1
Ozaki, N1
Itoh, A1
Kasahara, Y1
Griffiths, RR1
Lamb, RJ1
Ator, NA1
Roache, JD1
Brady, JV1
Sussman, N1
Jacoby, JA1
Olson, KR1
Yin, L1
Osterloh, J1
Tani, A1
Tan, TL1
Cadieux, RJ1
Goodman, AL1
Regestein, QR1
Reich, P1
Lanaia, F1
Scrofani, A1
Biondi, R1
Rodolico, F1
Moon, CA1
Hayes, G1
Cohen, SA3
Bliwise, NG3
Fancourt, G1
Castleden, M1
Clark, BG1
Jue, SG1
Dawson, GW1
Ward, A1
Mauro, C1
Sperlongano, P1
Fletcher, K1
Graham, JP1
Bliwise, DL1
Timms, RM1
Dawson, A1
Hajdukovic, RM1
Mitler, MM1
Baker, MI1
Oleen, MA1
Hegelbach-Feller, DA1
Tschopp, JM1
Christeller, S1
Fabre, J1
Harmatz, JS1
Zinny, MA1
Shader, RI1
Denson, R1
Turek, FW1
DiBella, GA1
Sakkas, PN1
Bergiannaki, JD1
Stefanis, CN1
Bayer, AJ1
Bayer, EM1
Pathy, MS1
Stoker, MJ1
Niklaus, DE1
Autret, E1
Autret, A1
Rungta, K1
Isomura, T1
McMillan, MJ1
Wittig, R1

Reviews

16 reviews available for triazolam and Sleep Initiation and Maintenance Disorders

ArticleYear
Triazolam: a review of its pharmacological properties and therapeutic efficacy in patients with insomnia.
    Drugs, 1981, Volume: 22, Issue:2

    Topics: Animals; Anti-Anxiety Agents; Clinical Trials as Topic; Cognition; Humans; Kinetics; Sleep Initiatio

1981
Clinical trials of hypnotics.
    Journal of clinical psychopharmacology, 1983, Volume: 3, Issue:2

    Topics: Anti-Anxiety Agents; Clinical Trials as Topic; Dose-Response Relationship, Drug; Flurazepam; Half-Li

1983
Sleep laboratory studies of hypnotic drugs: efficacy and withdrawal effects.
    Journal of clinical psychopharmacology, 1983, Volume: 3, Issue:2

    Topics: Anti-Anxiety Agents; Antidepressive Agents, Tricyclic; Anxiety; Dose-Response Relationship, Drug; Fl

1983
Rational basis for the use of sleeping pills.
    Pharmacology, 1983, Volume: 27 Suppl 2

    Topics: Anxiety; Chronic Disease; Flurazepam; Humans; Hypnotics and Sedatives; Kinetics; Sleep; Sleep Initia

1983
Issues in the diagnosis and treatment of insomnia.
    Psychopharmacology. Supplementum, 1984, Volume: 1

    Topics: Chronic Disease; Flurazepam; Humans; Hypnotics and Sedatives; Psychomotor Performance; Respiration;

1984
Zolpidem: distinct from triazolam?
    The Annals of pharmacotherapy, 1997, Volume: 31, Issue:5

    Topics: Humans; Hypnotics and Sedatives; Pyridines; Sleep Initiation and Maintenance Disorders; Triazolam; Z

1997
Comparative clinical profiles of triazolam versus other shorter-acting hypnotics.
    The Journal of clinical psychiatry, 1992, Volume: 53 Suppl

    Topics: Azabicyclo Compounds; Clinical Trials as Topic; Dose-Response Relationship, Drug; Humans; Hypnotics

1992
Review of triazolam data.
    The Journal of clinical psychiatry, 1992, Volume: 53 Suppl

    Topics: Age Factors; Aged; Clinical Trials as Topic; Clinical Trials, Phase II as Topic; Clinical Trials, Ph

1992
Disinhibition, amnestic reactions, and other adverse reactions secondary to triazolam: a review of the literature.
    The Journal of clinical psychiatry, 1992, Volume: 53 Suppl

    Topics: Amnesia; Benzodiazepines; Delirium; Double-Blind Method; Humans; Placebos; Randomized Controlled Tri

1992
A review of the safety profiles of benzodiazepine hypnotics.
    The Journal of clinical psychiatry, 1991, Volume: 52 Suppl

    Topics: Aged; Anti-Anxiety Agents; Benzodiazepines; Central Nervous System; Flurazepam; Half-Life; Humans; H

1991
Benzodiazepine hypnotics and insomnia.
    Hospital practice (Office ed.), 1990, Volume: 25 Suppl 3

    Topics: Anti-Anxiety Agents; Humans; Hypnotics and Sedatives; Psychotherapy; Sleep Initiation and Maintenanc

1990
Rebound insomnia: a critical review.
    Journal of clinical psychopharmacology, 1989, Volume: 9, Issue:3

    Topics: Anti-Anxiety Agents; Flurazepam; Humans; Sleep Initiation and Maintenance Disorders; Sleep Stages; S

1989
Relative abuse liability of triazolam: experimental assessment in animals and humans.
    Neuroscience and biobehavioral reviews, 1985,Spring, Volume: 9, Issue:1

    Topics: Amnesia; Animals; Anti-Anxiety Agents; Behavior, Animal; Discrimination, Psychological; Drug Interac

1985
Rebound insomnia and elimination half-life: assessment of individual subject response.
    Journal of clinical pharmacology, 1985, Volume: 25, Issue:2

    Topics: Adult; Anti-Anxiety Agents; Benzodiazepines; Clinical Trials as Topic; Dose-Response Relationship, D

1985
Loprazolam. A preliminary review of its pharmacodynamic and pharmacokinetic properties and therapeutic efficacy in insomnia.
    Drugs, 1986, Volume: 31, Issue:6

    Topics: Anti-Anxiety Agents; Benzodiazepines; Benzodiazepinones; Humans; Kinetics; Nitrazepam; Sleep; Sleep

1986
Behavioral side effects of benzodiazepine hypnotics.
    Clinical neuropharmacology, 1985, Volume: 8 Suppl 1

    Topics: Amnesia; Anti-Anxiety Agents; Anxiety; Benzodiazepines; Flurazepam; Humans; Hypnotics and Sedatives;

1985

Trials

76 trials available for triazolam and Sleep Initiation and Maintenance Disorders

ArticleYear
Effects of different doses of triazolam in the middle-of-the-night insomnia: a double-blind, randomized, parallel group study.
    Journal of neurology, 2017, Volume: 264, Issue:7

    Topics: Adult; Dose-Response Relationship, Drug; Double-Blind Method; Female; Humans; Hypnotics and Sedative

2017
Chronic use of triazolam: the effects on the sleep patterns of insomniacs.
    The Journal of international medical research, 1980, Volume: 8, Issue:3

    Topics: Adolescent; Adult; Anti-Anxiety Agents; Clinical Trials as Topic; Double-Blind Method; Female; Human

1980
A comparative study between two new benzodiazepine hypnotics.
    South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde, 1980, May-10, Volume: 57, Issue:19

    Topics: Adult; Anti-Anxiety Agents; Female; Flunitrazepam; Humans; Male; Middle Aged; Preoperative Care; Sle

1980
The efficacy of triazolam and chloral hydrate in geriatric insomniacs.
    The Journal of international medical research, 1980, Volume: 8, Issue:5

    Topics: Aged; Anti-Anxiety Agents; Chloral Hydrate; Clinical Trials as Topic; Double-Blind Method; Humans; M

1980
[Triazolam in the treatment of presurgical patients].
    Minerva chirurgica, 1980, Jun-30, Volume: 35, Issue:12

    Topics: Adult; Anti-Anxiety Agents; Female; Humans; Male; Middle Aged; Preoperative Care; Sleep; Sleep Initi

1980
Comparison of nitrazepam 5 mg with triazolam 0.5 mg in young psychiatric insomniac inpatients. Double-blind single night cross-over study.
    Acta psychiatrica Scandinavica, 1980, Volume: 62, Issue:5

    Topics: Adult; Anti-Anxiety Agents; Clinical Trials as Topic; Double-Blind Method; Humans; Male; Nitrazepam;

1980
Triazolam: a review of its pharmacological properties and therapeutic efficacy in patients with insomnia.
    Drugs, 1981, Volume: 22, Issue:2

    Topics: Animals; Anti-Anxiety Agents; Clinical Trials as Topic; Cognition; Humans; Kinetics; Sleep Initiatio

1981
[Experimental double-blind study of triazolam versus placebo].
    La Clinica terapeutica, 1981, May-15, Volume: 97, Issue:3

    Topics: Adult; Anti-Anxiety Agents; Clinical Trials as Topic; Female; Humans; Male; Middle Aged; Placebos; S

1981
Triazolam (Halcion) versus flunitrazepam (Rohypnol) against midwinter insomnia in Northern Norway.
    Acta psychiatrica Scandinavica, 1981, Volume: 64, Issue:3

    Topics: Adolescent; Adult; Anti-Anxiety Agents; Clinical Trials as Topic; Double-Blind Method; Female; Fluni

1981
Aspects of short-term use of two benzodiazepine hypnotics in the elderly.
    Age and ageing, 1982, Volume: 11, Issue:4

    Topics: Aged; Anti-Anxiety Agents; Clinical Trials as Topic; Dose-Response Relationship, Drug; Double-Blind

1982
Daytime carryover of triazolam and flurazepam in elderly insomniacs.
    Sleep, 1982, Volume: 5, Issue:4

    Topics: Aged; Anti-Anxiety Agents; Arousal; Clinical Trials as Topic; Emotions; Female; Flurazepam; Humans;

1982
Clinical trials of hypnotics.
    Journal of clinical psychopharmacology, 1983, Volume: 3, Issue:2

    Topics: Anti-Anxiety Agents; Clinical Trials as Topic; Dose-Response Relationship, Drug; Flurazepam; Half-Li

1983
Approaches in the evaluation of hypnotics: studies with triazolam.
    British journal of clinical pharmacology, 1981, Volume: 11 Suppl 1

    Topics: Anti-Anxiety Agents; Clinical Trials as Topic; Hospitalization; Humans; Psychomotor Performance; Sle

1981
A clinical trial of a new hypnotic--loprazolam.
    The British journal of clinical practice, 1983, Volume: 37, Issue:4

    Topics: Adult; Aged; Anti-Anxiety Agents; Benzodiazepines; Benzodiazepinones; Clinical Trials as Topic; Fema

1983
Midazolam and triazolam in out-patients: a double-blind comparison of hypnotic efficacy.
    British journal of clinical pharmacology, 1983, Volume: 16 Suppl 1

    Topics: Adult; Anti-Anxiety Agents; Benzodiazepines; Clinical Trials as Topic; Double-Blind Method; Female;

1983
Comparison of nitrazepam with triazolam in insomniac outpatients.
    Acta psychiatrica Scandinavica, 1982, Volume: 65, Issue:2

    Topics: Adult; Aged; Anti-Anxiety Agents; Clinical Trials as Topic; Double-Blind Method; Female; Humans; Mal

1982
Triazolam treatment of insomnia in depressed patients taking tricyclics.
    The Journal of clinical psychiatry, 1983, Volume: 44, Issue:11

    Topics: Adult; Anti-Anxiety Agents; Antidepressive Agents, Tricyclic; Clinical Trials as Topic; Depressive D

1983
Double-blind crossover comparison of triazolam and lorazepam in the posthypnotic state.
    The Journal of clinical psychiatry, 1984, Volume: 45, Issue:3

    Topics: Adolescent; Adult; Akathisia, Drug-Induced; Anti-Anxiety Agents; Clinical Trials as Topic; Dizziness

1984
Influence of triazolam on thermal heat balance in poor sleepers.
    European journal of clinical pharmacology, 1984, Volume: 27, Issue:2

    Topics: Adult; Anti-Anxiety Agents; Body Temperature; Body Temperature Regulation; Catecholamines; Dopamine;

1984
Zopiclone improves sleep quality and daytime well-being in insomniac patients: comparison with triazolam, flunitrazepam and placebo.
    International clinical psychopharmacology, 1994,Winter, Volume: 9, Issue:4

    Topics: Azabicyclo Compounds; Double-Blind Method; Female; Flunitrazepam; Humans; Male; Middle Aged; Piperaz

1994
Zolpidem and rebound insomnia--a double-blind, controlled polysomnographic study in chronic insomniac patients.
    Pharmacopsychiatry, 1994, Volume: 27, Issue:4

    Topics: Adult; Aged; Anxiety; Chronic Disease; Double-Blind Method; Female; Humans; Hypnotics and Sedatives;

1994
Randomized, double blind trial of zolpidem 10 mg versus triazolam 0.25 mg for treatment of insomnia in general practice.
    Scandinavian journal of primary health care, 1994, Volume: 12, Issue:2

    Topics: Adult; Aged; Circadian Rhythm; Double-Blind Method; Family Practice; Female; Humans; Hypnotics and S

1994
Insomnia in generalized anxiety disorder: polysomnographic, psychometric and clinical investigations before, during and after therapy with a long- versus a short-half-life benzodiazepine (quazepam versus triazolam).
    Neuropsychobiology, 1994, Volume: 29, Issue:2

    Topics: Adult; Anti-Anxiety Agents; Anxiety; Benzodiazepines; Double-Blind Method; Female; Humans; Hypnotics

1994
Effectiveness of combined triazolam-behavioral therapy for primary insomnia.
    The American journal of psychiatry, 1993, Volume: 150, Issue:8

    Topics: Adult; Behavior Therapy; Combined Modality Therapy; Female; Follow-Up Studies; Humans; Male; Placebo

1993
Feasibility of an every-other-night regimen in insomniac patients: subjective hypnotic effectiveness of quazepam, triazolam, and placebo.
    The Journal of clinical psychiatry, 1993, Volume: 54, Issue:1

    Topics: Anti-Anxiety Agents; Benzodiazepines; Circadian Rhythm; Double-Blind Method; Drug Administration Sch

1993
Changes of cyclic alternating pattern (CAP) parameters in situational insomnia under brotizolam and triazolam.
    Psychopharmacology, 1995, Volume: 120, Issue:3

    Topics: Adult; Animals; Azepines; Cricetinae; Electroencephalography; Female; Humans; Hypnotics and Sedative

1995
A new design of trial for hypnotics comparison: a double-blind cross-over trial with patient's preference assessment and continuation of the preferred treatment.
    Progress in neuro-psychopharmacology & biological psychiatry, 1996, Volume: 20, Issue:3

    Topics: Adult; Anti-Anxiety Agents; Benzodiazepines; Benzodiazepinones; Female; Humans; Male; Middle Aged; S

1996
Hypnotic self administration and dose escalation.
    Psychopharmacology, 1996, Volume: 127, Issue:2

    Topics: Adult; Cross-Over Studies; Double-Blind Method; Female; Humans; Hypnotics and Sedatives; Male; Middl

1996
Triazolam and diphenhydramine effects on seizure duration in depressed patients receiving ECT.
    Convulsive therapy, 1996, Volume: 12, Issue:4

    Topics: Adult; Aged; Depressive Disorder; Diphenhydramine; Electroconvulsive Therapy; Electroencephalography

1996
Minimal rebound insomnia after treatment with 10-mg zolpidem.
    Clinical neuropharmacology, 1997, Volume: 20, Issue:2

    Topics: Adult; Double-Blind Method; Female; Humans; Hypnotics and Sedatives; Male; Middle Aged; Polysomnogra

1997
[Halcion (triazolam) in the treatment of insomnia].
    Terapevticheskii arkhiv, 1997, Volume: 69, Issue:1

    Topics: Adult; Chronic Disease; Female; Humans; Hypnotics and Sedatives; Male; Middle Aged; Sleep Initiation

1997
Multidrug comparison (lorazepam, triazolam, zolpidem, and zopiclone) in situational insomnia: polysomnographic analysis by means of the cyclic alternating pattern.
    Clinical neuropharmacology, 1997, Volume: 20, Issue:3

    Topics: Adult; Azabicyclo Compounds; Female; Humans; Hypnotics and Sedatives; Lorazepam; Male; Middle Aged;

1997
Hypnotic self administration: forced-choice versus single-choice.
    Psychopharmacology, 1997, Volume: 133, Issue:2

    Topics: Adult; Affect; Double-Blind Method; Female; Humans; Hypnotics and Sedatives; Male; Middle Aged; Self

1997
Can we mix behavioral therapy with hypnotics when treating insomniacs?
    Sleep, 1997, Volume: 20, Issue:12

    Topics: Adult; Combined Modality Therapy; Female; Follow-Up Studies; Humans; Hypnotics and Sedatives; Male;

1997
Rebound insomnia after hypnotic withdrawal in insomniac outpatients.
    European archives of psychiatry and clinical neuroscience, 1998, Volume: 248, Issue:3

    Topics: Adolescent; Adult; Aged; Analysis of Variance; Anti-Anxiety Agents; Azabicyclo Compounds; Double-Bli

1998
Clinical applications of cyclic alternating pattern.
    Electroencephalography and clinical neurophysiology. Supplement, 1999, Volume: 50

    Topics: Acquired Immunodeficiency Syndrome; Adult; Anticonvulsants; Electroencephalography; GABA Modulators;

1999
Bright light treatment for night-time insomnia and daytime sleepiness in elderly people: comparison with a short-acting hypnotic.
    Psychiatry and clinical neurosciences, 2000, Volume: 54, Issue:3

    Topics: Aged; Aged, 80 and over; Cross-Over Studies; Humans; Hypnotics and Sedatives; Male; Middle Aged; Pho

2000
Treatment regimen and hypnotic self-administration.
    Psychopharmacology, 2001, Volume: 155, Issue:1

    Topics: Adult; Analysis of Variance; Anti-Anxiety Agents; Capsules; Female; Humans; Hypnotics and Sedatives;

2001
A double-blind, randomized and placebo-controlled study on the polysomnographic withdrawal effects of zopiclone, zolpidem and triazolam in healthy subjects.
    European archives of psychiatry and clinical neuroscience, 2001, Volume: 251, Issue:3

    Topics: Adult; Azabicyclo Compounds; Dose-Response Relationship, Drug; Double-Blind Method; Electroencephalo

2001
Nighttime versus daytime hypnotic self-administration.
    Psychopharmacology, 2002, Volume: 161, Issue:2

    Topics: Adult; Analysis of Variance; Anti-Anxiety Agents; Circadian Rhythm; Double-Blind Method; Female; Hum

2002
Multi-clinic cross-over comparison of triazolam (Halcion) and placebo in the treatment of co-existing insomnia and anxiety in anxious out-patients.
    Diseases of the nervous system, 1977, Volume: 38, Issue:6

    Topics: Adolescent; Adult; Ambulatory Care; Anti-Anxiety Agents; Anxiety; Drug Evaluation; Female; Humans; M

1977
Hypnotic efficacy of triazolam and methyprylon ininsomniac in-patients.
    The Journal of international medical research, 1976, Volume: 4, Issue:1

    Topics: Adult; Aged; Anti-Anxiety Agents; Clinical Trials as Topic; Female; Humans; Hypnotics and Sedatives;

1976
Intermediate use of triazolam: a sleep laboratory study.
    The Journal of international medical research, 1976, Volume: 4, Issue:1

    Topics: Adult; Anti-Anxiety Agents; Clinical Trials as Topic; Electroencephalography; Electromyography; Elec

1976
Preference studies of triazolam with standard hypnotics in out-patients with insomnia.
    The Journal of international medical research, 1976, Volume: 4, Issue:4

    Topics: Adolescent; Adult; Aged; Anti-Anxiety Agents; Chloral Hydrate; Clinical Trials as Topic; Double-Blin

1976
Multiclinic double-blind comparison of triazolam and flurazepam for seven nights in outpatients with insomnia.
    Journal of clinical pharmacology, 1977, Volume: 17, Issue:7

    Topics: Adolescent; Adult; Aged; Anti-Anxiety Agents; Clinical Trials as Topic; Double-Blind Method; Drug Ev

1977
Multi-clinic double-blind comparison of triazolam (Halcion) and placebo administered for 14 consecutive nights in outpatients with insomnia.
    The Journal of clinical psychiatry, 1978, Volume: 39, Issue:8

    Topics: Adolescent; Adult; Anti-Anxiety Agents; Clinical Trials as Topic; Double-Blind Method; Humans; Middl

1978
A clinical comparison of triazolam with placebo and with secobarbital in insomniac patients.
    The Journal of international medical research, 1978, Volume: 6, Issue:4

    Topics: Adult; Anti-Anxiety Agents; Clinical Trials as Topic; Double-Blind Method; Female; Humans; Male; Mid

1978
Comparative efficacy of triazolam, flurazepam and placebo in out-patients insomniacs.
    The Journal of international medical research, 1978, Volume: 6, Issue:4

    Topics: Adult; Anti-Anxiety Agents; Chronic Disease; Clinical Trials as Topic; Double-Blind Method; Female;

1978
Methodology for demonstrating sustained efficacy of hypnotics: a comparative study of triazolam and flurazepam.
    Clinical pharmacology and therapeutics, 1979, Volume: 25, Issue:4

    Topics: Adult; Anti-Anxiety Agents; Clinical Trials as Topic; Double-Blind Method; Flurazepam; Humans; Middl

1979
Model insomnia, noise, and methylphenidate, used for the evaluation of hypnotic drugs.
    Psychopharmacology, 1978, Apr-28, Volume: 57, Issue:2

    Topics: Adult; Drug Evaluation; Electroencephalography; Flurazepam; Humans; Hypnotics and Sedatives; Male; M

1978
A double-blind comparison of the effects of temazepam and triazolam on residual, daytime performance in elderly insomniacs.
    International psychogeriatrics, 1992,Summer, Volume: 4, Issue:1

    Topics: Aged; Cognition; Double-Blind Method; Female; Geriatric Assessment; Humans; Male; Neuropsychological

1992
Rebound insomnia in normals and patients with insomnia after abrupt and tapered discontinuation.
    Psychopharmacology, 1992, Volume: 108, Issue:1-2

    Topics: Adult; Double-Blind Method; Female; Humans; Male; Middle Aged; Sleep Initiation and Maintenance Diso

1992
Rebound insomnia and hypnotic self administration.
    Psychopharmacology, 1992, Volume: 107, Issue:4

    Topics: Adult; Double-Blind Method; Female; Humans; Hypnotics and Sedatives; Male; Middle Aged; Self Adminis

1992
Next-day memory impairment with triazolam use.
    Lancet (London, England), 1991, Apr-06, Volume: 337, Issue:8745

    Topics: Activities of Daily Living; Adolescent; Adult; Amnesia, Retrograde; Capsules; Double-Blind Method; D

1991
Rebound insomnia: duration of use and individual differences.
    Journal of clinical psychopharmacology, 1991, Volume: 11, Issue:6

    Topics: Adult; Drug Tolerance; Electroencephalography; Humans; Male; Monitoring, Physiologic; Sleep Initiati

1991
Efficacy of behavioral versus triazolam treatment in persistent sleep-onset insomnia.
    The American journal of psychiatry, 1991, Volume: 148, Issue:1

    Topics: Adult; Behavior Therapy; Evaluation Studies as Topic; Female; Follow-Up Studies; Humans; Male; Perso

1991
Rebound insomnia after only brief and intermittent use of rapidly eliminated benzodiazepines.
    Clinical pharmacology and therapeutics, 1991, Volume: 49, Issue:4

    Topics: Adult; Female; Humans; Male; Middle Aged; Monitoring, Physiologic; Random Allocation; Sleep Initiati

1991
A comparative study of zopiclone and triazolam in patients with insomnia.
    International clinical psychopharmacology, 1990, Volume: 5 Suppl 2

    Topics: Adult; Aged; Arousal; Azabicyclo Compounds; Double-Blind Method; Female; Humans; Hypnotics and Sedat

1990
A comparison of the efficacy, safety and withdrawal effects of zopiclone and triazolam in the treatment of insomnia.
    International clinical psychopharmacology, 1990, Volume: 5 Suppl 2

    Topics: Adolescent; Adult; Azabicyclo Compounds; Double-Blind Method; Female; Humans; Hypnotics and Sedative

1990
Efficacy and safety of zopiclone and triazolam in the treatment of geriatric insomniacs.
    International clinical psychopharmacology, 1990, Volume: 5 Suppl 2

    Topics: Aged; Aged, 80 and over; Arousal; Azabicyclo Compounds; Dose-Response Relationship, Drug; Double-Bli

1990
Zopiclone versus triazolam in insomniac geriatric patients: a specific increase in delta sleep with zopiclone.
    International clinical psychopharmacology, 1990, Volume: 5 Suppl 2

    Topics: Aged; Aged, 80 and over; Arousal; Azabicyclo Compounds; Delta Rhythm; Double-Blind Method; Electroen

1990
Zopiclone and triazolam in insomnia associated with generalized anxiety disorder: a placebo-controlled evaluation of efficacy and daytime anxiety.
    International clinical psychopharmacology, 1990, Volume: 5, Issue:3

    Topics: Adult; Anxiety Disorders; Azabicyclo Compounds; Drug Administration Schedule; Female; Humans; Hypnot

1990
The effects of a single night's dosing with triazolam on sleep the following night.
    Journal of clinical pharmacology, 1990, Volume: 30, Issue:6

    Topics: Adult; Dose-Response Relationship, Drug; Female; Humans; Male; Middle Aged; Random Allocation; Sleep

1990
Rebound insomnia and elimination half-life: assessment of individual subject response.
    Journal of clinical pharmacology, 1985, Volume: 25, Issue:2

    Topics: Adult; Anti-Anxiety Agents; Benzodiazepines; Clinical Trials as Topic; Dose-Response Relationship, D

1985
Early morning insomnia and daytime anxiety--a multicentre general practice study comparing loprazolam and triazolam.
    The British journal of clinical practice, 1985, Volume: 39, Issue:9

    Topics: Adolescent; Adult; Aged; Anti-Anxiety Agents; Anxiety Disorders; Benzodiazepines; Benzodiazepinones;

1985
Buspirone: an anxiolytic without sedative effect.
    Psychopharmacology, 1985, Volume: 87, Issue:3

    Topics: Adult; Anti-Anxiety Agents; Buspirone; Chronic Disease; Clinical Trials as Topic; Double-Blind Metho

1985
Comparative amnestic effects of benzodiazepine hypnotic agents.
    The Journal of clinical psychiatry, 1988, Volume: 49, Issue:4

    Topics: Adult; Amnesia; Anti-Anxiety Agents; Dose-Response Relationship, Drug; Humans; Memory, Short-Term; M

1988
Profile of mood states changes during and after 5 weeks of nightly triazolam administration.
    The Journal of clinical psychiatry, 1988, Volume: 49, Issue:9

    Topics: Adult; Anxiety Disorders; Clinical Trials as Topic; Double-Blind Method; Female; Humans; Male; MMPI;

1988
Effect of triazolam on sleep and arterial oxygen saturation in patients with chronic obstructive pulmonary disease.
    Archives of internal medicine, 1988, Volume: 148, Issue:10

    Topics: Aged; Double-Blind Method; Female; Humans; Hypercapnia; Hypoxia; Lung Diseases, Obstructive; Male; M

1988
Comparison of the short-acting benzodiazepines midazolam and triazolam with placebo.
    Arzneimittel-Forschung, 1988, Volume: 38, Issue:3

    Topics: Adult; Aged; Clinical Trials as Topic; Double-Blind Method; Dreams; Female; Humans; Male; Midazolam;

1988
Effect of gradual withdrawal on the rebound sleep disorder after discontinuation of triazolam.
    The New England journal of medicine, 1987, Sep-17, Volume: 317, Issue:12

    Topics: Adult; Clinical Trials as Topic; Double-Blind Method; Drug Administration Schedule; Female; Humans;

1987
Behavioral side effects of triazolam in psychiatric inpatients: report of five cases.
    Drug intelligence & clinical pharmacy, 1986, Volume: 20, Issue:4

    Topics: Adult; Clinical Trials as Topic; Depression; Double-Blind Method; Female; Hospitalization; Humans; M

1986
A double-blind controlled study of chlormethiazole and triazolam as hypnotics in the elderly.
    Acta psychiatrica Scandinavica. Supplementum, 1986, Volume: 329

    Topics: Aged; Arousal; Chlormethiazole; Clinical Trials as Topic; Double-Blind Method; Female; Flicker Fusio

1986
Comparison of short and long half-life benzodiazepine hypnotics: triazolam and quazepam.
    Clinical pharmacology and therapeutics, 1986, Volume: 40, Issue:4

    Topics: Adult; Aged; Anti-Anxiety Agents; Benzodiazepines; Clinical Trials as Topic; Double-Blind Method; Dr

1986
Comparison of the clinical hypnotic effects of zopiclone and triazolam.
    European journal of clinical pharmacology, 1987, Volume: 31, Issue:5

    Topics: Adult; Azabicyclo Compounds; Clinical Trials as Topic; Double-Blind Method; Female; Humans; Hypnotic

1987
Dose-related effects of triazolam and flurazepam on a circadian rhythm insomnia.
    Clinical pharmacology and therapeutics, 1986, Volume: 40, Issue:3

    Topics: Adult; Circadian Rhythm; Dose-Response Relationship, Drug; Double-Blind Method; Flurazepam; Humans;

1986

Other Studies

81 other studies available for triazolam and Sleep Initiation and Maintenance Disorders

ArticleYear
Outdoor Artificial Nighttime Light and Use of Hypnotic Medications in Older Adults: A Population-Based Cohort Study.
    Journal of clinical sleep medicine : JCSM : official publication of the American Academy of Sleep Medicine, 2018, 11-15, Volume: 14, Issue:11

    Topics: Age Factors; Aged; Cohort Studies; Drug Utilization Review; Female; Humans; Hypnotics and Sedatives;

2018
Quantification of adverse effects of regular use of triazolam on clinical outcomes for older people with insomnia: a retrospective cohort study.
    International journal of geriatric psychiatry, 2016, Volume: 31, Issue:2

    Topics: Aged; Aged, 80 and over; Anti-Anxiety Agents; Female; Humans; Hypnotics and Sedatives; Japan; Male;

2016
Rebound insomnia induced by abrupt withdrawal of hypnotics in sleep-disturbed rats.
    European journal of pharmacology, 2008, Nov-12, Volume: 597, Issue:1-3

    Topics: Animals; Diazepam; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Administration Sch

2008
Effects of ramelteon and triazolam in a mouse genetic model of early morning awakenings.
    Brain research, 2009, Nov-03, Volume: 1296

    Topics: Animals; Circadian Rhythm; Darkness; Disease Models, Animal; Indenes; Locomotion; Male; Mice; Mice,

2009
Retrograde effects of triazolam and zolpidem on sleep-dependent motor learning in humans.
    Journal of sleep research, 2010, Volume: 19, Issue:1 Pt 2

    Topics: Adult; Arousal; Cognition Disorders; Disorders of Excessive Somnolence; Dose-Response Relationship,

2010
Pharmacokinetic evaluation of eszopiclone: clinical and therapeutic implications.
    Expert opinion on drug metabolism & toxicology, 2012, Volume: 8, Issue:12

    Topics: Acetamides; Adult; Aged; Azabicyclo Compounds; Clinical Trials as Topic; Cytochrome P-450 CYP3A; Cyt

2012
Electroencephalographic properties of zaleplon, a non-benzodiazepine sedative/hypnotic, in rats.
    Journal of pharmacological sciences, 2004, Volume: 94, Issue:3

    Topics: Acetamides; Administration, Oral; Animals; Azabicyclo Compounds; Cerebral Cortex; Dose-Response Rela

2004
On the sleep promoting effects of BR-16A: interaction with GABAergic modulators.
    Indian journal of experimental biology, 2004, Volume: 42, Issue:5

    Topics: Alprazolam; Animals; Dose-Response Relationship, Drug; Drug Interactions; Female; GABA Agonists; GAB

2004
Effectiveness and safety of hypnotic drugs in the treatment of insomnia in over 70-year old people.
    Archives of gerontology and geriatrics, 2007, Volume: 44 Suppl 1

    Topics: Aged; Cognition Disorders; Dementia; Depression; Drug Administration Schedule; Female; Health Status

2007
[Therapy of insomnia].
    MMW, Munchener medizinische Wochenschrift, 1980, Mar-07, Volume: 122, Issue:10

    Topics: Anti-Anxiety Agents; Drug Evaluation; Humans; Placebos; Sleep Initiation and Maintenance Disorders;

1980
[Episodes of anterograde amnesia associated with the use of triazolam].
    L'union medicale du Canada, 1980, Volume: 109, Issue:3

    Topics: Adult; Amnesia; Anti-Anxiety Agents; Female; Humans; Male; Middle Aged; Sleep Initiation and Mainten

1980
Hypnotic effects of a benzodiazepine derivative: a clinical observation.
    International pharmacopsychiatry, 1982, Volume: 17, Issue:1

    Topics: Adult; Aged; Ambulatory Care; Anti-Anxiety Agents; Double-Blind Method; Female; Hospitalization; Hum

1982
[Evaluation of the hypnotic activity of triazolam in comparison with flunitrazepam].
    Il Farmaco; edizione pratica, 1982, Volume: 37, Issue:5

    Topics: Adult; Aged; Anti-Anxiety Agents; Female; Flunitrazepam; Humans; Male; Middle Aged; Sleep Initiation

1982
Daytime alertness, insomnia, and benzodiazepines.
    Sleep, 1982, Volume: 5 Suppl 1

    Topics: Adult; Anti-Anxiety Agents; Arousal; Benzodiazepines; Double-Blind Method; Flurazepam; Humans; Loraz

1982
Benzodiazepine hypnotics increase heart rate during sleep.
    Sleep, 1982, Volume: 5, Issue:3

    Topics: Administration, Oral; Adult; Anti-Anxiety Agents; Flurazepam; Heart Rate; Humans; Male; Sleep; Sleep

1982
[Effects of the chronic administration of triazolam 0.50 mg on the sleep of insomniacs].
    La Nouvelle presse medicale, 1982, Oct-14, Volume: 11, Issue:40

    Topics: Adult; Anti-Anxiety Agents; Drug Evaluation; Female; Humans; Male; Middle Aged; Sleep; Sleep Initiat

1982
Triazolam--a new benzodiazepine for insomnia.
    The Medical letter on drugs and therapeutics, 1983, Mar-18, Volume: 25, Issue:631

    Topics: Anti-Anxiety Agents; Humans; Sleep Initiation and Maintenance Disorders; Triazolam

1983
Early morning insomnia with rapidly eliminated benzodiazepines.
    Science (New York, N.Y.), 1983, Apr-01, Volume: 220, Issue:4592

    Topics: Anti-Anxiety Agents; Benzodiazepines; Flurazepam; Half-Life; Humans; Midazolam; Sleep; Sleep Initiat

1983
Triazolam compared with nitrazepam and with oxazepam in insomnia: two double-blind, crossover studies analyzed sequentially.
    British journal of clinical pharmacology, 1981, Volume: 11 Suppl 1

    Topics: Adolescent; Adult; Aged; Anti-Anxiety Agents; Double-Blind Method; Female; Humans; Male; Middle Aged

1981
Triazolam: monitored release in the United Kingdom.
    British journal of clinical pharmacology, 1981, Volume: 11 Suppl 1

    Topics: Adolescent; Adult; Aged; Anti-Anxiety Agents; Child; Female; Humans; Male; Middle Aged; Sleep Initia

1981
Double-blind trial of triazolam 0.5 mg vs. nitrazepam 5 mg in outpatients.
    Acta psychiatrica Scandinavica, 1983, Volume: 67, Issue:3

    Topics: Adolescent; Adult; Anti-Anxiety Agents; Arousal; Double-Blind Method; Female; Humans; Male; Middle A

1983
Triazolam as a hypnotic for geriatric patients. A double-blind cross-over comparison of nitrazepam and triazolam regarding effects on sleep and psychomotor performance.
    Acta psychiatrica Scandinavica, 1983, Volume: 67, Issue:5

    Topics: Aged; Anti-Anxiety Agents; Double-Blind Method; Female; Humans; Male; Motor Skills; Nitrazepam; Slee

1983
Triazolam abuse.
    Canadian Medical Association journal, 1983, Aug-15, Volume: 129, Issue:4

    Topics: Adult; Alcoholism; Anti-Anxiety Agents; Humans; Male; Sleep Initiation and Maintenance Disorders; Su

1983
Daytime sleepiness as a criterion in hypnotic medication trials: comparison of triazolam and flurazepam.
    Sleep, 1983, Volume: 6, Issue:2

    Topics: Adult; Anti-Anxiety Agents; Arousal; Double-Blind Method; Female; Flurazepam; Humans; Male; Sleep In

1983
[Our electroencephalographic data in the framework of a review on lormetazepam].
    La Clinica terapeutica, 1984, May-15, Volume: 109, Issue:3

    Topics: Adult; Aged; Anti-Anxiety Agents; Benzodiazepines; Electroencephalography; Female; Humans; Lorazepam

1984
Inadvertent benzodiazepine withdrawal.
    American family physician, 1984, Volume: 30, Issue:4

    Topics: Anti-Anxiety Agents; Flurazepam; Humans; Male; Middle Aged; Sleep Initiation and Maintenance Disorde

1984
Sleep spindle and delta changes during chronic use of a short-acting and a long-acting benzodiazepine hypnotic.
    Electroencephalography and clinical neurophysiology, 1983, Volume: 55, Issue:6

    Topics: Adult; Anti-Anxiety Agents; Brain; Double-Blind Method; Electroencephalography; Female; Flurazepam;

1983
Studies with modern hypnotics.
    Irish journal of medical science, 1984, Volume: 153, Issue:8

    Topics: Anxiety; Benzodiazepines; Humans; Hypnotics and Sedatives; Sleep Initiation and Maintenance Disorder

1984
Hypnotics: rebound insomnia and residual sequelae.
    British journal of clinical pharmacology, 1980, Volume: 9, Issue:3

    Topics: Humans; Hypnotics and Sedatives; Sleep Initiation and Maintenance Disorders; Substance Withdrawal Sy

1980
[Does a rebound insomnia following benzodiazepine administration exist?].
    Deutsche medizinische Wochenschrift (1946), 1980, Oct-24, Volume: 105, Issue:43

    Topics: Benzodiazepines; Diazepam; Flunitrazepam; Flurazepam; Humans; Nitrazepam; Sleep Initiation and Maint

1980
[Between the two...].
    L'union medicale du Canada, 1980, Volume: 109, Issue:10

    Topics: Aged; Flurazepam; Humans; Hypnotics and Sedatives; Sleep; Sleep Initiation and Maintenance Disorders

1980
Long-term follow-up study of 10 adolescent patients with sleep-wake schedule disorders.
    The Japanese journal of psychiatry and neurology, 1994, Volume: 48, Issue:1

    Topics: Adolescent; Behavior Therapy; Circadian Rhythm; Combined Modality Therapy; Female; Follow-Up Studies

1994
Photic maculopathy resulting from the light of a video camera in patients taking triazolam.
    Ophthalmologica. Journal international d'ophtalmologie. International journal of ophthalmology. Zeitschrift fur Augenheilkunde, 1994, Volume: 208, Issue:3

    Topics: Female; Humans; Light; Macula Lutea; Male; Middle Aged; Pupil; Radiation Injuries; Retinal Diseases;

1994
Article questioned.
    The Journal of clinical psychiatry, 1994, Volume: 55, Issue:4

    Topics: Anti-Anxiety Agents; Benzodiazepines; Humans; Peer Review; Periodicals as Topic; Placebos; Research

1994
Adverse events after triazolam substitution.
    Lancet (London, England), 1993, Jan-02, Volume: 341, Issue:8836

    Topics: Aged; Anti-Anxiety Agents; Female; Humans; Male; Retrospective Studies; Sleep Initiation and Mainten

1993
Short acting benzodiazepines.
    BMJ (Clinical research ed.), 1993, Apr-10, Volume: 306, Issue:6883

    Topics: Amnesia; Anti-Anxiety Agents; Anxiety; Depression; Half-Life; Humans; Sleep Initiation and Maintenan

1993
Management of insomnia in office-based practice. National prevalence and therapeutic patterns.
    Archives of family medicine, 1993, Volume: 2, Issue:11

    Topics: Adolescent; Adult; Aged; Data Collection; Female; Flurazepam; Humans; Male; Medicine; Middle Aged; P

1993
Hypnotic drug use in Spain: a cross-sectional study based on a network of community pharmacies. Spanish Group for the Study of Hypnotic Drug Utilization.
    The Annals of pharmacotherapy, 1996, Volume: 30, Issue:10

    Topics: Administration, Oral; Aged; Dose-Response Relationship, Drug; Drug and Narcotic Control; Female; Hum

1996
Hallucinations after a therapeutic dose of benzodiazepine hypnotics with co-administration of erythromycin.
    Psychiatry and clinical neurosciences, 1996, Volume: 50, Issue:6

    Topics: Anti-Anxiety Agents; Drug Therapy, Combination; Erythromycin; Hallucinations; Humans; Kidney Failure

1996
Insomnia.
    The New England journal of medicine, 1997, Jun-26, Volume: 336, Issue:26

    Topics: Humans; Hypnotics and Sedatives; Pyridines; Sleep Initiation and Maintenance Disorders; Triazolam; Z

1997
Comment: zolpidem: distinct from triazolam?
    The Annals of pharmacotherapy, 1997, Volume: 31, Issue:11

    Topics: Humans; Hypnotics and Sedatives; Pyridines; Sleep Initiation and Maintenance Disorders; Triazolam; Z

1997
Report of the Institute of Medicine Committee on the Efficacy and Safety of Halcion.
    Archives of general psychiatry, 1999, Volume: 56, Issue:4

    Topics: Adverse Drug Reaction Reporting Systems; Chronic Disease; Drug Approval; Drug Evaluation; Evaluation

1999
The report by the Institute of Medicine and postmarketing surveillance.
    Archives of general psychiatry, 1999, Volume: 56, Issue:4

    Topics: Clinical Trials as Topic; Drug Approval; Evaluation Studies as Topic; Humans; Hypnotics and Sedative

1999
Long-term use of sedative and hypnotic medication.
    Archives of general psychiatry, 1999, Volume: 56, Issue:4

    Topics: Drug Approval; Evaluation Studies as Topic; Humans; Hypnotics and Sedatives; National Academies of S

1999
Fulminant hepatic failure associated with triazolam.
    Digestive diseases and sciences, 2002, Volume: 47, Issue:5

    Topics: Anti-Anxiety Agents; Female; Humans; Liver Failure; Middle Aged; Sleep Initiation and Maintenance Di

2002
Pilot open-label study of triazolam in the treatment of insomnia following alcohol withdrawal.
    Journal of studies on alcohol, 1977, Volume: 38, Issue:11

    Topics: Adult; Alcoholism; Anti-Anxiety Agents; Anxiety; Drug Evaluation; Female; Humans; Male; Middle Aged;

1977
[Comparison of the hypnotic activity of triazolam and flurazepam].
    L'union medicale du Canada, 1979, Volume: 108, Issue:2

    Topics: Adult; Anti-Anxiety Agents; Evaluation Studies as Topic; Female; Flurazepam; Humans; Male; Middle Ag

1979
Hypnotics today.
    The Practitioner, 1979, Volume: 223, Issue:1336

    Topics: Aged; Anti-Anxiety Agents; Diazepam; Electroencephalography; Humans; Sleep; Sleep Initiation and Mai

1979
Two more benzodiazepines.
    Drug and therapeutics bulletin, 1979, Aug-17, Volume: 17, Issue:17

    Topics: Anti-Anxiety Agents; Anxiety; Benzodiazepinones; Humans; Sleep Initiation and Maintenance Disorders;

1979
Rebound insomnia. A potential hazard following withdrawal of certain benzodiazepines.
    JAMA, 1979, Apr-20, Volume: 241, Issue:16

    Topics: Acute Disease; Benzodiazepines; Flunitrazepam; Half-Life; Humans; Nitrazepam; Sleep Initiation and M

1979
Rebound insomnia: a new clinical syndrome.
    Science (New York, N.Y.), 1978, Sep-15, Volume: 201, Issue:4360

    Topics: Benzodiazepines; Brain; Flunitrazepam; Humans; Hypnotics and Sedatives; Nitrazepam; Receptors, Drug;

1978
New labeling and patient insert for triazolam approved by FDA.
    Clinical pharmacy, 1992, Volume: 11, Issue:6

    Topics: Drug Labeling; Humans; Sleep Initiation and Maintenance Disorders; Triazolam; United States; United

1992
Clinical uses and advantages of low doses of benzodiazepine hypnotics.
    The Journal of clinical psychiatry, 1992, Volume: 53 Suppl

    Topics: Adult; Aged; Amnesia; Benzodiazepines; Dose-Response Relationship, Drug; Drug Administration Schedul

1992
Diagnosis and treatment of outpatient insomnia by psychiatric and nonpsychiatric physicians.
    The American journal of medicine, 1992, Volume: 93, Issue:1

    Topics: Disease; Drug Prescriptions; Drug Utilization; Female; Flurazepam; General Surgery; Humans; Internal

1992
Triazolam-induced nocturnal bingeing with amnesia.
    The Australian and New Zealand journal of psychiatry, 1992, Volume: 26, Issue:2

    Topics: Amnesia; Female; Humans; Hyperphagia; Middle Aged; Obesity; Sleep Initiation and Maintenance Disorde

1992
Triazolam accumulation in the elderly after prolonged use.
    The American journal of psychiatry, 1991, Volume: 148, Issue:9

    Topics: Adult; Aged; Aged, 80 and over; Female; Half-Life; Humans; Male; Middle Aged; Radioligand Assay; Rec

1991
Avoiding the blanket approach to insomnia. Targeted therapy for specific causes.
    Postgraduate medicine, 1991, Volume: 90, Issue:1

    Topics: Anti-Anxiety Agents; Benzodiazepines; Chronic Disease; Diagnosis, Differential; Estazolam; Flurazepa

1991
Nocturnal wandering caused by restless legs and short-acting benzodiazepines.
    Acta psychiatrica Scandinavica, 1991, Volume: 83, Issue:6

    Topics: Anti-Anxiety Agents; Benserazide; Drug Therapy, Combination; Humans; Levodopa; Male; Middle Aged; My

1991
Specificity of memory impairments with triazolam use.
    Lancet (London, England), 1991, Oct-05, Volume: 338, Issue:8771

    Topics: Benzodiazepines; Dose-Response Relationship, Drug; Humans; Memory Disorders; Memory, Short-Term; Sle

1991
Triazolam--the never-ending story.
    DICP : the annals of pharmacotherapy, 1991, Volume: 25, Issue:11

    Topics: Amnesia; Delirium; Humans; Sleep Initiation and Maintenance Disorders; Triazolam

1991
Triazolam side effects in parkinsonism.
    The New Zealand medical journal, 1991, Nov-13, Volume: 104, Issue:923

    Topics: Aged; Delirium; Female; Humans; Male; Parkinson Disease; Sleep Initiation and Maintenance Disorders;

1991
The beneficial and adverse effects of hypnotics.
    The Journal of clinical psychiatry, 1991, Volume: 52 Suppl

    Topics: Adolescent; Adult; Aged; Attitude to Health; Benzodiazepines; Data Collection; Drug Prescriptions; E

1991
Diagnosis and management of insomnia.
    The New England journal of medicine, 1990, Aug-16, Volume: 323, Issue:7

    Topics: Humans; Sleep Initiation and Maintenance Disorders; Triazolam

1990
Motor phenomena in benzodiazepine withdrawal.
    Hospital & community psychiatry, 1989, Volume: 40, Issue:12

    Topics: Aged; Alprazolam; Anti-Anxiety Agents; Diagnosis, Differential; Diazepam; Drug Therapy, Combination;

1989
Evaluation of long-term triazolam use in an ambulatory Veterans Administration Medical Center population.
    DICP : the annals of pharmacotherapy, 1989, Volume: 23, Issue:4

    Topics: Drug Prescriptions; Drug Tolerance; Evaluation Studies as Topic; Hospitals, Veterans; Humans; Middle

1989
A treatment trial of delayed sleep phase syndrome with triazolam.
    The Japanese journal of psychiatry and neurology, 1989, Volume: 43, Issue:1

    Topics: Adult; Arousal; Circadian Rhythm; Depressive Disorder; Dose-Response Relationship, Drug; Drug Admini

1989
Comment: long-term triazolam use.
    DICP : the annals of pharmacotherapy, 1989, Volume: 23, Issue:10

    Topics: Aged; Humans; Hypnotics and Sedatives; Sleep Initiation and Maintenance Disorders; Triazolam

1989
Putting benzodiazepine hypnotics into proper therapeutic perspective.
    The Journal of the Medical Society of New Jersey, 1985, Volume: 82, Issue:3

    Topics: Anti-Anxiety Agents; Flurazepam; Humans; Sleep Initiation and Maintenance Disorders; Temazepam; Tria

1985
Coma caused by trivial triazolam overdose.
    The American journal of emergency medicine, 1985, Volume: 3, Issue:3

    Topics: Adult; Anti-Anxiety Agents; Coma; Female; Headache; Humans; Sleep Initiation and Maintenance Disorde

1985
Early morning insomnia, daytime anxiety, and organic mental disorder associated with triazolam.
    The Journal of family practice, 1985, Volume: 20, Issue:6

    Topics: Adult; Anti-Anxiety Agents; Anxiety; Humans; Male; Sleep Initiation and Maintenance Disorders; Subst

1985
Agitation observed during treatment with newer hypnotic drugs.
    The Journal of clinical psychiatry, 1985, Volume: 46, Issue:7

    Topics: Adult; Aged; Akathisia, Drug-Induced; Anger; Anti-Anxiety Agents; Female; Half-Life; Hostility; Huma

1985
[Efficacy and tolerance of triazolam compared with flurazepam in patients with insomnia].
    La Clinica terapeutica, 1985, Apr-15, Volume: 113, Issue:1

    Topics: Adolescent; Adult; Anti-Anxiety Agents; Drug Tolerance; Female; Flurazepam; Humans; Male; Middle Age

1985
The use of benzodiazepines with particular reference to the elderly.
    British journal of hospital medicine, 1986, Volume: 35, Issue:5

    Topics: Aged; Anti-Anxiety Agents; Anxiety; Chlordiazepoxide; Diazepam; Humans; Infusions, Parenteral; Kinet

1986
[Controlled clinical evaluation of 2 hypnotic triazole benzodiazepines, estazolam and triazolam, used the night before surgical interventions].
    Minerva medica, 1987, Sep-30, Volume: 78, Issue:18

    Topics: Adult; Anti-Anxiety Agents; Estazolam; Female; Humans; Male; Middle Aged; Premedication; Sleep; Slee

1987
The use of benzodiazepine hypnotics in the elderly.
    Pharmacotherapy, 1988, Volume: 8, Issue:4

    Topics: Adolescent; Age Factors; Aged; Aged, 80 and over; Canada; Drug Interactions; Drug Prescriptions; Dru

1988
Involuntary self-intoxication with triazolam.
    Psychiatric journal of the University of Ottawa : Revue de psychiatrie de l'Universite d'Ottawa, 1987, Volume: 12, Issue:4

    Topics: Crime; Humans; Male; Middle Aged; Psychoses, Substance-Induced; Sleep Initiation and Maintenance Dis

1987
Manipulation of a central circadian clock regulating behavioral and endocrine rhythms with a short-acting benzodiazepine used in the treatment of insomnia.
    Psychoneuroendocrinology, 1988, Volume: 13, Issue:3

    Topics: Animals; Circadian Rhythm; Cricetinae; Dark Adaptation; Dose-Response Relationship, Drug; Female; Lu

1988
Update on hypnotics for insomnia in clinical practice: I. Hypnotics.
    The Mount Sinai journal of medicine, New York, 1986, Volume: 53, Issue:2

    Topics: Adult; Humans; Hypnotics and Sedatives; Sleep Initiation and Maintenance Disorders; Temazepam; Triaz

1986
Withdrawal regimen for triazolam-dependent patients.
    CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne, 1986, Jun-01, Volume: 134, Issue:11

    Topics: Diazepam; Flurazepam; Humans; Sleep Initiation and Maintenance Disorders; Substance Withdrawal Syndr

1986
Effects of quazepam and triazolam on the sleep of chronic insomniacs: a comparative 25-night sleep laboratory study.
    Clinical neuropharmacology, 1985, Volume: 8 Suppl 1

    Topics: Adult; Anti-Anxiety Agents; Benzodiazepines; Chronic Disease; Drug Tolerance; Female; Humans; Male;

1985
Efficacy of a reduced triazolam dose in elderly insomniacs.
    Neurobiology of aging, 1985,Winter, Volume: 6, Issue:4

    Topics: Aged; Female; Humans; Male; Middle Aged; Sleep Initiation and Maintenance Disorders; Triazolam

1985
chemdatabank.com